Photochemoprevention by botanical antioxidants

Skin Pharmacology and Applied Skin Physiology

Volumn 15, Issue 5, 2002, Pages 297-306

  Afaq, Farrukh ^a   Mukhtar, Hasan ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Medical Science   (United States)

Author keywords

Botanical antioxidants; Photochemoprevention

Indexed keywords

ANTIOXIDANT; APIGENIN; BLACK TEA EXTRACT; CAFFEINE; CURCUMIN; GREEN TEA EXTRACT; PHYTOALEXIN; PLANT EXTRACT; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RESVERATROL; SILYMARIN; SUNSCREEN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CONFERENCE PAPER; DRUG EFFECT; HUMAN; NONHUMAN; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CARCINOGENESIS; SKIN CARCINOMA; SUN EXPOSURE; TEA; ULTRAVIOLET RADIATION;

ANIMALS; ANTIOXIDANTS; BEVERAGES; FLAVONOIDS; HUMANS; PHENOLS; PHYTOTHERAPY; POLYMERS; SKIN; SKIN NEOPLASMS; TEA; ULTRAVIOLET RAYS;

EID: 0036378813     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064533     Document Type: Conference Paper

References (90)

1. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Der-matol 1994;30:774-778.
2. Mukhtar H, Elmets CA: Photocarcinogenesis: Mechanisms, models and human health implications. Photochem Photobiol 1996;63:356-357.
3. Cole CA, Forbes PD, Davies RE: An action spectrum for UV photocarcinogenesis. Photochem Photobiol 1986;43:275-284.
4. De Gruijl FR, Sterenborg HJCM, Forbes PD, Davies RE, Cole C, Kelfkens G, van Weelden H, Slaper H, van der Leun JC: Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res 1993;53:53-60.
5. Marks R: An overview of skin cancers. Incidence and causation. Cancer 1995;75(2 suppl):607-612.
6. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
7. Kwa RE, Campana K, Moy RL: Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;26:1-26.
8. Miller SJ: Biology of basal cell carcinoma. Part 1. J Am Acad Dermatol 1991;24:1-13.
9. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer Statistics, 2000. CA Cancer J Clin 2000;50:7-33.
10. Lang PG Jr: Malignant melanoma. Med Clin North Am 1998;82:1325-1358.
11. Pfeifer GP, Steigerwald SD, Hansen RS, Gartler SM, Riggs AD: Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: Methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc Natl Acad Sci USA 1990;87:8252-8256.
12. Noonan FP, De Fabo EC: Immunosuppression of ultraviolet B radiation: Initiation by urocanic acid. Immunol Today 1992;13:250-254.
13. Kripke ML, Cox PA, Las LG, Yarosh DB: Pyrimidine dimers in DNA intiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 1992;89:7516-7520.
14. Goihman-Yahr M: Skin aging and photoaging: An outlook. Clin Dermatol 1996;14:153-160.
15. Young AR: Cumulative effects of ultraviolet radiation on the skin: Cancer and photoaging. Semin Dermatol 1990;9:25-31.
16. Afaq F, Mukhtar H: Effects of solar radiation on cutaneous detoxification pathway. J Photochem Photobiol B 2001;63:61-69.
17. Godar DE, Wengraitis SP, Shreffler J, Sliney DH: UV doses of Americans. Photochem Photobiol 2001;73:621-629.
18. Berton TR, Mitchell DL, Fischer SM, Locniskar MF: Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Invest Dermatol 1997;109:340-347.
19. Li G, Mitchell DL, Ho VC, Reed JC, Tron VA: Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol 1996;148:1113-1123.
20. Peak MJ, Ito A, Foote CS, Peak JG: Photosensitized inactivation of DNA by monochromatic 334-nm radiation in the presence of 2-thiouracil: Genetic activity and backbone breaks. Photochem Photobiol 1988;47:809-813.
21. Mukhtar H, Ahmad N: Cancer chemoprevention: Future holds in multiple agents. Toxicol Appl Pharmacol 1999;158:207-210.
22. Ahmad N, Mukhtar H: Cutaneous photochemoprevention by green tea: A brief review. Skin Pharmacol Appl Skin Physiol 2001;14:69-76.
23. Afaq F, Adhami VM, Ahmad N, Mukhtar H: Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci 2002;7:d784-d792.
24. Ames BN: Dietry carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983;221:1256-1264.
25. Block G: Micronutrients and cancer: Time for action? J Natl Cancer Inst 1993;85:846-848.
26. Katiyar SK, Mukhtar H: Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl 1997;27:59-67.
27. Katiyar SK, Afaq F, Perez A, Mukhtar H: Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 2001;22:287-294.
28. Mukhtar H, Agarwal R: Skin cancer chemoprevention. J Investig Dermatol Symp Proc 1996;1:209-214.
29. Ley RD, Reeve VE: Chemoprevention of ultraviolet radiation-induced skin cancer. Environ Health Perspect 1997;105(suppl 4):981-984.
30. Lu Y-P, Lou Y-R, Lin Y, Shih WJ, Huang M-T, Yang CS, Conney AH: Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk-mice): Relationship to decreased tissue fat. Cancer Res 2001;61:5002-5009.
31. Birt DF, Pelling JC, Nair S, Lepley D: Diet intervention by modifying cancer risk. Prog Clin Biol Res 1996;395:223-234.
32. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H: Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 2001;176:110-117.
33. Katiyar SK, Mukhtar H: Tea in chemoprevention of cancer: Epidemiologic and experimental studies. Int J Oncol 1996;8:221-238.
34. Afaq F, Mukhtar H, Ahmad N: Protective effects of resveratrol against short-term markers of photocarcinogenesis in a mouse skin model. J Invest Dermatol 2001;117:505.
35. Birt DF, Mitchell DL, Gold B, Pour P, Pinch HC: Inhibition of ultraviolet light-induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 1997;17:85-92.
36. Huang MT, Newmark HL, Frenkel K: Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 1997;27:26-34.
37. Mukhtar H, Wang ZY, Katiyar SK, Agarwal R: Tea components: Antimutagenic and anticarcinogenic effects. Prev Med 1992;21:351-360.
38. Dong Z, Ma WY, Huang CS, Yang CS: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419.
39. Katiyar SK, Ahmad N, Mukhtar H: Green tea and skin. Arch Dermatol 2000;136:989-994.
40. Wang ZY, Agarwal R, Bickers DR, Mukhtar H: Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 1991;12:1527-1530.
41. Katiyar SK, Mohan RR, Agarwal R, Mukhtar H: Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis 1997;18:497-502.
42. Agarwal R, Katiyar SK, Khan SG, Mukhtar H: Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem Photobiol 1993;58:695-700.
43. Katiyar SK, Elmets CA, Agarwal R, Mukhtar H: Protection against ultraviolet B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 1995;62:855-861.
44. Katiyar SK, Challa A, McCormick S, Cooper KD, Mukhtar H: Reversal of ultraviolet B-induced immunosuppression in mice by green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999;20:2117-2124.
45. Katiyar SK, Mukhtar H: Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen presenting cells, and oxidative stress. J Leukoc Biol 2001;69:719-726.
46. Agarwal R, Katiyar SK, Zaidi SIA, Mukhtar H: Inhibition of tumor promoter-caused induction of ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res 1992;52:3582-3588.
47. Wang ZY, Huang MT, Lou YR, Xie JG, Reuhl K, Newmark HL, Ho CT, Yang CS, Conney AH: Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res 1994;54:3428-3435.
48. Wang ZY, Huang MT, Ho CT, Chang R, Ma W, Ferraro T, Reuhl KR, Yang CS, Conney AH: Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 1992;52:6657-6665.
49. Lu YP, Lou YR, Li XH, Xie JG, Brash D, Huang MT, Conney AH: Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21 (WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 2000;60:4785-4791.
50. Katiyar SK, Agarwal R, Mukhtar H: Inhibition of spontaneous and photo-enhanced lipid peroxidation in mouse epidermal microsomes by epicatechin derivatives from green tea. Cancer Lett 1994;79:61-66.
51. Kim J, Hwang JS, Cho YK, Han Y, Jeon YJ, Yang KH: Protective effects of (-)-epigallocatechin-3-gallate on UVA- and UVB-induced skin damage. Skin Pharmacol Appl Skin Physiol 2001;14:11-19.
52. Uchara M, Sugiura H, Sakurai K: A trial of oolong tea in the management of recalcitrant atopic dermatitis. Arch Dermatol 2001;137:42-43.
53. Barthelman M, Bair WB 3rd, Stickland KK, Chen W, Timmermann BN, Valcic S, et al: (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 1998;19:2201-2204.
54. Nomura M, Ma WY, Huang C, Yang CS, Bowden GT, Miyamoto K, Dong Z: Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea. Mol Carcinog 2000;28:148-155.
55. Nomura M, Kaji A, He Z, Ma WY, Miyamoto K, Yang CS, Dong Z: Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2001;276:46624-46631.
56. Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT: Inhibition of ultraviolet B-induced c-fos gene expression and p-38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 1999;24:79-84.
57. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H: Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 1999;69:148-153.
58. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar SK, Mukhtar H: Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001;44:425-432.
59. Katiyar SK, Perez A, Mukhtar H: Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clin Cancer Res 2000;6:3864-3869.
60. Sharma OP: Antioxidative activity of curcumin and related compounds. Biochem Pharmacol 1976;25:1811-1812.
61. Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973;25:447-452.
62. Sugiyama Y, Kawakishi S, Osawa T: Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 1996;52:519-525.
63. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Sen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.
64. Surh YJ: Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999;428:305-327.
65. Soudamini KK, Kuttan R: Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 1989;27:227-233.
66. Nagabhushan M, Bhide SV: Curcumin, an inhibitor of cancer. J Am Coll Nutr 1992;11:192-198.
67. Parshad R, Sanford KK, Price FM, Steele VE, Tarone RE, Kelloff GJ, Boone CW: Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells. Anticancer Res 1998;18:3263-3266.
68. Huang MT, Newmark HL, Frenkel K: Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 1997;27:26-34.
69. Oda Y: Inhibitory effect of curcumin on SOS functions induced by UV irradiation. Mutat Res 1995;348:67-73.
70. Shah RG, Netrawali MS: Evaluation of mutagenic activity of turmeric extract containing curcumin, before and after activation with mammalian cecal microbial extract of liver microsomal fraction, in the Ames Salmonella test. Bull Environ Contam Toxicol 1988;40:350-357.
71. Iersel ML, Ploemen JP, Struik I, van Amersfoort C, Keyzer AE, Scheffer-lie JG, van Bladeren JP: Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 1996;102:117-132.
72. Cuendet M, Pezzuto JM: The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact 2000;17:109-157.
73. Chen YR, Tan TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998;17:173-178.
74. Ishizaki C, Oguro T, Yoshida T, Wen CQ, Sueki H, Iijima M: Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-O-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dematology 1996;193:311-317.
75. Oguro T, Yoshida T: Effect of ultraviolet A on ornithine decarboxylase and metallothionein gene expression in mouse skin. Photodermatol Photoimmunol Photomed 2001;17:71-78.
76. Van Iersel ML, Ploemen JP, Lo Bello M, Federici G, van Bladere PJ: Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem Biol Interact 1997;108:67-78.
77. Jee SH, Shen SC, Tseng CR, Chiu HC, Kuo ML: Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 1998;11:656-661.
78. Mereish KA, Bunner DL, Ragland DR, Creasia DA: Protection against microcystin-LR-induced hepatotoxicity by silymarin: Biochemistry, histopathology and lethality. Pharm Res 1991;8:273-277.
79. Wagner VH, Diesel P, Seitz M: The chemistry and analysis of silymarin from Silybum marianum Gaertn. Arzneimittelforschung 1974;24:466-471.
80. Comoglio A, Leonarduzzi G, Carini R, Busolin D, Basaga H, Albano E, Tomasi A, Polio G, Morazzoni P, Magistretti MJ: Studies on the antioxidant and free radical scavenging properties of IdB 1016:A new flavanolignan complex. Free Radic Res Commun 1990;11:109-115.
81. Katiyar SK, Korman NJ, Mukhtar H, Agarwal R: Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 1997;89:556-566.
82. Chatterjee ML, Agarwal R, Mukhtar H: Ultraviolet B radiation-induced DNA lesions in mouse epidermis: An assessment using novel 32P-postlabelling technique. Biochem Biophys Res Commun 1996;229:590-595.
83. Saliou C, Kitazawa M, McLaughlin L, Yang JP, Lodge JK, Tetsuka T, Iwasaki K, Cillard J, Okamoto T, Packer L: Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line. Free Radic Biol Med 1999;26:174-183.
84. 2/M arrest in keratinocytes. Carcinogenesis 1996;17:2367-2375.
85. Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB: Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;67:255-262.
86. McVean M, Xiao H, Isobe K, Pelling JC: Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis 2001;21:633-639.
87. 2/M arrest by the chemopreventive flavonoid apigenin. Mol Carcinog 2002;33:36-43.
88. Tsai SH, Lin-Shiau SY, Lin JK: Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophage by resveratrol. Br J Pharmacol 1999;126:673-680.
89. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875-21882.
90. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezutto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.